Viyash Scientific Limited (SEQUENT) - Total Liabilities
Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has total liabilities worth Rs8.40 Billion INR (≈ $90.80 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See SEQUENT defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Viyash Scientific Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Viyash Scientific Limited's total liabilities have evolved over time, based on quarterly financial data. Check SEQUENT asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Viyash Scientific Limited Competitors by Total Liabilities
The table below lists competitors of Viyash Scientific Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sinon Corp
TW:1712
|
Taiwan | NT$7.59 Billion |
|
Shenzhen Sosen Electronics Co.Ltd.
SHE:301002
|
China | CN¥662.61 Million |
|
Hypoport SE
XETRA:HYQ
|
Germany | €308.32 Million |
|
Gokaldas Exports Limited
NSE:GOKEX
|
India | Rs21.94 Billion |
|
Kambi Group PLC Series B
LSE:0EAW
|
UK | Skr37.87 Million |
|
Nanfang Ventilator Co Ltd
SHE:300004
|
China | CN¥325.82 Million |
|
Pagerduty Inc
NYSE:PD
|
USA | $719.85 Million |
|
Yaari Digital Integrated Services Limited
NSE:YAARI
|
India | Rs11.02 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Viyash Scientific Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SEQUENT total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Viyash Scientific Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Viyash Scientific Limited (2006–2025)
The table below shows the annual total liabilities of Viyash Scientific Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs8.32 Billion ≈ $89.93 Million |
+0.50% |
| 2024-03-31 | Rs8.27 Billion ≈ $89.48 Million |
+6.09% |
| 2023-03-31 | Rs7.80 Billion ≈ $84.35 Million |
+9.72% |
| 2022-03-31 | Rs7.11 Billion ≈ $76.88 Million |
+15.35% |
| 2021-03-31 | Rs6.16 Billion ≈ $66.64 Million |
-15.68% |
| 2020-03-31 | Rs7.31 Billion ≈ $79.03 Million |
+14.02% |
| 2019-03-31 | Rs6.41 Billion ≈ $69.31 Million |
-2.62% |
| 2018-03-31 | Rs6.58 Billion ≈ $71.18 Million |
-27.72% |
| 2017-03-31 | Rs9.11 Billion ≈ $98.48 Million |
+56.96% |
| 2016-03-31 | Rs5.80 Billion ≈ $62.74 Million |
-13.34% |
| 2015-03-31 | Rs6.69 Billion ≈ $72.40 Million |
+19.25% |
| 2014-03-31 | Rs5.61 Billion ≈ $60.71 Million |
+15.36% |
| 2013-03-31 | Rs4.87 Billion ≈ $52.63 Million |
+16.06% |
| 2012-03-31 | Rs4.19 Billion ≈ $45.35 Million |
+33.18% |
| 2011-03-31 | Rs3.15 Billion ≈ $34.05 Million |
+16.54% |
| 2010-03-31 | Rs2.70 Billion ≈ $29.22 Million |
+25.68% |
| 2009-03-31 | Rs2.15 Billion ≈ $23.25 Million |
+400.41% |
| 2008-03-31 | Rs429.63 Million ≈ $4.65 Million |
+188.32% |
| 2007-03-31 | Rs149.01 Million ≈ $1.61 Million |
+94.73% |
| 2006-03-31 | Rs76.52 Million ≈ $827.57K |
-- |
About Viyash Scientific Limited
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more